Joseph Fernandez-Moure

Dr. Joseph Fernandez-Moure

Department of Surgery, Duke University Medical Center, Duke University, Durham, NC, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
MVMichael A. Vella
Michael A. Vella
AWAlexander Warshauer
Alexander Warshauer
GTGabriella Tortorello
Gabriella Tortorello
JFJoseph Fernandez-Moure
Joseph Fernandez-Moure
JGJoseph Giacolone
Joseph Giacolone
MSMark J. Seamon
Mark J. Seamon
The effects of firearm violence in the United States are devastating. From 1999 to 2013, 462 043 US individuals were killed by firearms.1 The gun-related homicide rate in the United States is 25 times higher than in other high-income countries2 and appears to be increasing.3 In 2017, the Centers for Disease Control and Prevention reported that US firearm-related homicides reached their highest peak since tracking of these data began 40 years ago.4 The mean initial hospitalization costs related to firearm injuries are estimated at $735 million per year, with an increasing burden placed on taxpayers.5,6

3 June 2016 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
JFJoseph Fernandez-Moure
Joseph Fernandez-Moure
The evolution of medicine and medical technology hinges on the successful translation of basic science research from the bench to clinical implementation at the bedside. Born out of the increasing need to facilitate the transfer of scientific knowledge to patients, translational research has emerged. Significant leaps in improving global health such as antibiotics, vaccinations, and cancer therapies have all seen successes under this paradigm yet today it has become increasingly difficult to realize this ideal scenario. As hospital revenue demand increase, and financial support declines, clinician protected research time has been limited. Researchers, likewise, have been forced to abandon time and resource consuming translational research to focus on publication generating work to maintain funding and professional advancement. Compared to the surge in scientific innovation and new fields of science have surged, realization of transformational scientific findings in device development and materials sciences has significantly lagged behind. Herein, we describe: how the current scientific paradigm struggles in the new health-care landscape; the obstacles met by translational researchers; and solutions, both public and private, to overcoming those obstacles. We must rethink the old dogma of academia and reinvent the traditional pathways of research in order to truly impact the health-care arena and ultimately those that matter most: the patient.

1 January 2017 in Journal of Surgical Research
Verified
Journal Article
Closed access
JFJoseph Fernandez-Moure
Joseph Fernandez-Moure
JEJeffrey L. Van Eps
Jeffrey L. Van Eps
FCFernando J. Cabrera
Fernando J. Cabrera
ZBZonia Barbosa
Zonia Barbosa
GRGuillermo Medrano del Rosal
Guillermo Medrano del Rosal
ETEnnio Tasciotti
Ennio Tasciotti

15 April 2013 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
DFDaniel Fine
Daniel Fine
AGAlessandro Grattoni
Alessandro Grattoni
RGRandy Goodall
Randy Goodall
SBShyam S. Bansal
Shyam S. Bansal
CCCiro Chiappini
Ciro Chiappini
MFMauro Ferrari
Mauro Ferrari

26 October 2015 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
JFJoseph Fernandez-Moure
Joseph Fernandez-Moure
BCBruna Corradetti
Bruna Corradetti
PCPaige Chan
Paige Chan
JEJeffrey L. Van Eps
Jeffrey L. Van Eps
TJTrevor Janecek
Trevor Janecek
ETEnnio Tasciotti
Ennio Tasciotti
Introduction: Mesenchymal stem cells (MSCs) hold great promise for regenerative therapies in the musculoskeletal system. Although MSCs from bone marrow (BM-MSCs) and adipose tissue (AD-MSCs) have been extensively characterized, there is still debate as to the ideal source of MSCs for tissue-engineering applications in bone repair.Methods: MSCs were isolated from cortical bone fragments (CBF-MSCs) obtained from patients undergoing laminectomy, selected by fluorescence-activated cell sorting analysis, and tested for their potential to undergo mesodermic differentiation. CBF-MSCs were then compared with BM-MSCs and AD-MSCs for their colony-forming unit capability and osteogenic potential in both normoxia and hypoxia. After 2 and 4 weeks in inducing media, differentiation was assessed qualitatively and quantitatively by the evaluation of alkaline phosphatase (ALP) expression and mineral deposition (Von Kossa staining). Transcriptional activity of osteoblastogenesis-associated genes (Alp,RUNX2,Spp1, andBglap) was also analyzed.Results: The cortical fraction of the bone contains a subset of cells positive for MSC-associated markers and capable of tri-lineage differentiation. The hypoxic conditions were generally more effective in inducing osteogenesis for the three cell lines. However, at 2 and 4 weeks, greater calcium deposition and ALP expression were observed in both hypoxic and normoxic conditions in CBF-MSCs compared with AD- and BM-MSCs. These functional observations were further corroborated by gene expression analysis, which showed a significant upregulation ofBglap,Alp, andSpp1, with a 22.50 (±4.55)-, 46.56 (±7.4)-, 71.46 (±4.16)-fold increase compared with their uninduced counterparts.Conclusions: This novel population of MSCs retains a greater biosynthetic activityin vitro, which was found increased in hypoxic conditions. The present study demonstrates that quantitative differences between MSCs retrieved from bone marrow, adipose, and the cortical portion of the bone with respect to their osteogenic potential exist and suggests the cortical bone as suitable candidate to use for orthopedic tissue engineering and regenerative medicine.

1 March 2019 in Materials Today Bio
Verified
Journal Article
Open access
SMSilvia Minardi
Silvia Minardi
FTFrancesca Taraballi
Francesca Taraballi
FCF.J. Cabrera
F.J. Cabrera
JEJ. Van Eps
J. Van Eps
XWX. Wang
X. Wang
ETE. Tasciotti
E. Tasciotti
Synthetic osteoinductive materials that mimic the human osteogenic niche have emerged as ideal candidates to address this area of unmet clinical need. In this study, we evaluated the osteoinductive potential in a rabbit orthotopic model of a magnesium-doped hydroxyapatite/type I collagen ​(MHA/Coll) composite. The composite was fabricated to exhibit a highly fibrous structure of carbonated MHA with 70% (±2.1) porosity and a Ca/P ratio of 1.5 (±0.03) as well as a diverse range of elasticity separated to two distinct stiffness peaks of low (2.35 ​± ​1.16 ​MPa) and higher (9.52 ​± ​2.10 ​MPa) Young's Modulus. Data suggested that these specific compositional and nanomechanical material properties induced the deposition of de novo mineral phase, while modulating the expression of early and late osteogenic marker genes, in a 3D in vitro model using human bone marrow-derived mesenchymal stem cells (hBM-MSCs). When tested in the rabbit orthotopic model, MHA/Col1 scaffold induction of new trabecular bone mass was observed by DynaCT scan, only 2 weeks after implantation. Bone histomorphometry at 6 weeks revealed a significant amount of de novo bone matrix formation. qPCR demonstrated MHA/Coll scaffold full cellularization in vivo and the expression of both osteogenesis-associated genes (Spp1, Sparc, Col1a1, Runx2, Dlx5) as well as hematopoietic (Vcam1, Cd38, Sele, Kdr) and bone marrow stromal cell marker genes (Vim, Itgb1, Alcam). Altogether, these data provide ​evidence of the solid osteoinductive potential of MHA/Coll and its suitability for multiple approaches of bone regeneration.